Nov 14 (Reuters) - Radiation therapy products developer North American Scientific Inc. (NASI.O: Quote, Profile, Research) said it received U.S. regulatory marketing approval for its high-dose rate radiation treatment design of ClearPath, a breast cancer treatment device.
